S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Save $300 on MarketBeat All Access (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The single greatest medical breakthrough of all time? (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The single greatest medical breakthrough of all time? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Save $300 on MarketBeat All Access (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The single greatest medical breakthrough of all time? (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The single greatest medical breakthrough of all time? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Save $300 on MarketBeat All Access (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The single greatest medical breakthrough of all time? (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The single greatest medical breakthrough of all time? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Save $300 on MarketBeat All Access (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The single greatest medical breakthrough of all time? (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The single greatest medical breakthrough of all time? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NYSE:LH

Laboratory Co. of America (LH) Stock Forecast, Price & News

$208.42
+3.27 (+1.59%)
(As of 09/25/2023 ET)
Compare
Today's Range
$203.89
$208.50
50-Day Range
$201.17
$221.84
52-Week Range
$166.93
$222.33
Volume
1.02 million shs
Average Volume
749,673 shs
Market Capitalization
$18.47 billion
P/E Ratio
22.48
Dividend Yield
1.38%
Price Target
$244.55

Laboratory Co. of America MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
17.3% Upside
$244.55 Price Target
Short Interest
Healthy
5.78% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.50mentions of Laboratory Co. of America in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$1.11 M Sold Last Quarter
Proj. Earnings Growth
7.46%
From $13.68 to $14.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.04 out of 5 stars

Medical Sector

32nd out of 962 stocks

Medical Laboratories Industry

1st out of 23 stocks


LH stock logo

About Laboratory Co. of America (NYSE:LH) Stock

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

LH Price History

LH Stock News Headlines

Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
Bear of the Day: Labcorp (LH)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Laboratory Co. of America (NYSE:LH) Receives "Buy" Rating from Mizuho
Laboratory (LH) Gets a Buy from Mizuho Securities
Fortrea Stock Drops After Reporting Results
See More Headlines
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.

LH Company Calendar

Last Earnings
7/27/2023
Ex-Dividend for 9/8 Dividend
8/07/2023
Dividend Payable
9/08/2023
Today
9/25/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
50540R40
Employees
80,000
Year Founded
1995

Price Target and Rating

Average Stock Price Forecast
$244.55
High Stock Price Forecast
$270.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+17.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$1.28 billion
Pretax Margin
7.56%

Debt

Sales & Book Value

Annual Sales
$14.88 billion
Cash Flow
$31.34 per share
Book Value
$113.96 per share

Miscellaneous

Free Float
88,024,000
Market Cap
$18.47 billion
Optionable
Optionable
Beta
1.08

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Adam H. Schechter (Age 58)
    Pres, CEO & Chairman
    Comp: $3.72M
  • Mr. Glenn A. EisenbergMr. Glenn A. Eisenberg (Age 62)
    CFO & Exec. VP
    Comp: $1.54M
  • Mr. Mark S. Schroeder (Age 62)
    Exec. VP, Pres of Diagnostics Laboratories & COO
    Comp: $1.06M
  • Dr. Brian J. Caveney J.D. (Age 49)
    M.D., M.P.H., MPH, EVP, Pres of Early Devel. Research Laboratories & Chief Medical Officer
    Comp: $1.22M
  • Mr. Peter J. WilkinsonMr. Peter J. Wilkinson (Age 51)
    Sr. VP & Chief Accounting Officer
  • Mr. Lance V. Berberian (Age 60)
    Exec. VP and Chief Information & Technology Officer
  • Dr. Marcia T. Eisenberg Ph.D. (Age 64)
    Chief Scientific Officer & Sr. VP
  • Chas Cook
    VP of Investor Relations
  • Ms. Sandra D. van der Vaart (Age 63)
    Exec. VP, Chief Legal Officer, Chief Compliance Officer & Corp. Sec.
  • Ms. Amy B. SummyMs. Amy B. Summy (Age 56)
    Exec. VP & Chief Marketing Officer













LH Stock - Frequently Asked Questions

Should I buy or sell Laboratory Co. of America stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LH shares.
View LH analyst ratings
or view top-rated stocks.

What is Laboratory Co. of America's stock price forecast for 2023?

10 brokerages have issued 12 month price objectives for Laboratory Co. of America's stock. Their LH share price forecasts range from $210.00 to $270.00. On average, they predict the company's stock price to reach $244.55 in the next twelve months. This suggests a possible upside of 17.3% from the stock's current price.
View analysts price targets for LH
or view top-rated stocks among Wall Street analysts.

How have LH shares performed in 2023?

Laboratory Co. of America's stock was trading at $235.48 on January 1st, 2023. Since then, LH shares have decreased by 11.5% and is now trading at $208.42.
View the best growth stocks for 2023 here
.

When is Laboratory Co. of America's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our LH earnings forecast
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) posted its earnings results on Thursday, July, 27th. The medical research company reported $3.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.47 by $0.05. The medical research company had revenue of $3.03 billion for the quarter, compared to analysts' expectations of $3.77 billion. Laboratory Co. of America had a trailing twelve-month return on equity of 14.62% and a net margin of 5.89%. Laboratory Co. of America's revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm earned $4.96 earnings per share.
Read the conference call transcript
.

How often does Laboratory Co. of America pay dividends? What is the dividend yield for Laboratory Co. of America?

Laboratory Co. of America announced a quarterly dividend on Thursday, July 13th. Stockholders of record on Tuesday, August 8th will be paid a dividend of $0.72 per share on Friday, September 8th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date of this dividend is Monday, August 7th.
Read our dividend analysis for LH
.

Is Laboratory Co. of America a good dividend stock?

Laboratory Co. of America (NYSE:LH) pays an annual dividend of $2.88 per share and currently has a dividend yield of 1.40%. The dividend payout ratio is 31.07%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LH will have a dividend payout ratio of 19.59% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LH.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America updated its FY 2026 earnings guidance on Friday, September, 15th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $14.00B-.

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America Chief Executive Officer Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (14.34%), State Street Corp (4.44%), Geode Capital Management LLC (2.12%), Lazard Asset Management LLC (1.95%), Dimensional Fund Advisors LP (1.65%) and Northern Trust Corp (1.13%). Insiders that own company stock include Amy B Summy, Brian J Caveney, Der Vaart Sandra D Van, Dwight Gary Gilliland, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, Peter M Neupert and R Sanders Williams.
View institutional ownership trends
.

How do I buy shares of Laboratory Co. of America?

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $208.42.

How much money does Laboratory Co. of America make?

Laboratory Co. of America (NYSE:LH) has a market capitalization of $18.47 billion and generates $14.88 billion in revenue each year. The medical research company earns $1.28 billion in net income (profit) each year or $9.27 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

The company employs 80,000 workers across the globe.

Does Laboratory Co. of America have any subsidiaries?
The following companies are subsidiares of Laboratory Co. of America: 1957285 Ontario Inc. dba Quality Underwriting Services, 2089729 Ontario Inc., 2248848 Ontario Inc., 3065619 Nova Scotia Company, 3257959 Nova Scotia Company, 8165335 Canada Inc., 8348596 Canada Inc., 896988 Ontario Limited, 9279-3280 Quebec Inc., Accupath Diagnostic Laboratories Inc., Assets of Pathology Inc, Beacon LBS IPA Inc., Beacon Laboratory Benefit Solutions Inc., CannAmm GP Inc., CannAmm Limited Partnership, Center for Disease Detection International, Center for Disease Detection LLC, Centrex Clinical Laboratories Inc., Chiltern, Clearstone Central Laboratories (U.S.) Inc., Clearstone Holdings (International) Ltd., Clinical Outreach Laboratory Services, Clipper Holdings Inc., Colorado Coagulation Consultants Inc., Colorado Laboratory Services LLC, Correlagen Diagnostics Inc., Covance Inc., Curalab Inc., Cytometry Associates Inc., Czura Thornton (Hong Kong) Limited, DCL Acquisition Inc., DCL Medical Laboratories LLC, DCL Sub LLC, DIANON Systems Inc., DL Holdings Limited Partnership, Decision Diagnostics L.L.C. (aka DaVinici/Medicorp LLC), Diagnostic Services Inc., DynaLifeDX, Dynacare - Gamma Laboratory Partnership, Dynacare Company, Dynacare G.P. Inc., Dynacare Holdco LLC, Dynacare Laboratories Inc., Dynacare Laboratories Limited Partnership, Dynacare Northwest Inc., Dynacare Realty Inc., DynalifeDX Infrastructure Inc., Envigo's nonclinical contract research services business, Esoterix Genetic Counseling LLC, Esoterix Genetic Laboratories LLC, Esoterix Inc., Execmed Health Services Inc., FirstSource Laboratory Solutions Inc., GDML Medical Laboratories Inc, Gamma Dynacare Central Medical Laboratories GP Inc., Gamma Dynacare Central Medical Laboratory Limited Partnership, HHLA Lab-In-An-Envelope LLC, Health Testing Centers Inc., Health Trans Services Inc., Home Healthcare Laboratory of America LLC, IDX Pathology Inc., Impact Genetics Corporation, Impact Genetics Inc., Kaleida LabCorp LLC, Lab Delivery Service of New York City Inc., LabCorp BVBA, LabCorp Belgium Holdings Inc., LabCorp Central Laboratories (Canada) Inc., LabCorp Central Laboratories (China) Inc., LabCorp Colorado Inc., LabCorp Development Company, LabCorp Employer Services Inc., LabCorp Health System Diagnostics LLC, LabCorp Indiana Inc., LabCorp Japan G.K., LabCorp Limited, LabCorp Michigan Inc., LabCorp Nebraska Inc., LabCorp Neon Ltd., LabCorp Neon Switzerland S.à.r.l., LabCorp Specialty Testing Billing Service Inc., LabCorp Specialty Testing Group Inc., LabCorp Staffing Solutions Inc., LabCorp Tennessee LLC, LabCorp UK Holdings Ltd., LabWest Inc., Laboratoire Bio-Medic Inc., Laboratory Corporation of America, Lifecodes Corporation, LipoScience Inc., Litholink Corporation, MEDTOX Scientific Inc., MNG Laboratories, MedAxio Insurance Medical Services GP Inc., MedAxio Insurance Medical Services LP, Medical Neurogenitics LLC, Medtox Diagnostics Inc., Medtox Laboratories Inc., Monogram Biosciences Inc., Monogram Biosciences UK Limited, Myriad Autoimmune’s Vectra Testing Business, NWT Inc., National Genetics Institute, New Brighton Business Center LLC, New Imaging Diagnostics LLC, New Molecular Diagnostics Ventures LLC, Orchid Cellmark ULC, Ovia Health, PA Labs Inc., Paclab LLC, Path Lab Incorporated, Pathology Associates Medical Lab LLC, Pee Dee Pathology Associates Inc., Personal Genome Diagnostics Inc., Persys Technology Inc., Pixel by LabCorp, Princeton Diagnostic Laboratories of America Inc., Protedyne Corporation, SW/DL LLC, Saint Josephs-PAML LLC, Sequenom Biosciences (India) Pvt. Ltd., Sequenom Inc, Sequenom Inc., Tandem Labs Inc., Toxikon Corporation, Tri-Cities Laboratory LLC, Viro-Med Laboratories Inc., Visiun, and Yakima Medical Arts Inc..
Read More
How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The official website for the company is www.labcorp.com. The medical research company can be reached via phone at (336) 229-1127, via email at investor@labcorp.com, or via fax at 336-513-4510.

This page (NYSE:LH) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -